Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Stockholders Equity of $1.34 million for the year ending 2025.
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -88.2% in Stockholders Equity from 2024 to 2025.
- This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
- XBRL data for this metric is available from 2011 to 2025 (24 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $205.77 million | Q4 2014: $209.52 million | Q1 2015: $213.88 million | Q3 2015: $222.30 million | Q4 2015: $225.15 million | Q1 2016: $205.06 million | Q3 2016: $215.30 million | Q4 2016: $218.01 million | Q1 2017: $222.61 million | Q3 2017: $229.56 million | Q4 2017: $231.19 million | Q1 2018: $248.63 million | Q3 2018: $253.38 million | Q4 2018: $253.57 million | Q1 2019: $270.06 million | Q3 2019: $264.95 million | Q4 2019: $259.08 million | Q1 2020: $247.67 million | Q3 2022: $77.88 million | Q4 2022: $71.14 million | Q1 2023: $35.02 million | Q3 2023: -$13.56 million | Q4 2023: $1.42 million | Q1 2024: $17.69 million | Q2 2024: $11.32 million | Q3 2024: -$3.94 million | Q4 2024: $15.45 million | Q1 2025: $2.23 million | Q2 2025: $1.34 million | Q2 2025: -$861.0 thousand | Q3 2025: -$10.54 million.
- Over the full 24 years of available data (2011 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Stockholders Equity has declined by 99.0%.
- Historical annual values: Fiscal year 2025: $1.34 million | Fiscal year 2024: $11.32 million | Fiscal year 2023: -$4.23 million | Fiscal year 2023: $35.02 million | Fiscal year 2022: $71.14 million | Fiscal year 2022: $77.88 million | Fiscal year 2022: $87.82 million | Fiscal year 2022: $142.56 million | Fiscal year 2021: $155.42 million | Fiscal year 2021: $193.12 million | Fiscal year 2021: $201.95 million | Fiscal year 2021: $202.20 million | Fiscal year 2020: $208.00 million | Fiscal year 2020: $218.54 million | Fiscal year 2020: $229.84 million | Fiscal year 2019: $270.14 million | Fiscal year 2018: $252.56 million | Fiscal year 2017: $226.61 million | Fiscal year 2016: $210.73 million | Fiscal year 2015: $218.43 million | Fiscal year 2014: $203.07 million | Fiscal year 2013: $178.69 million | Fiscal year 2012: $149.74 million | Fiscal year 2011: $136.06 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: